A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C

The hepatitis C virus (HCV) infects more than 180 million people worldwide, with long-term consequences including liver failure and hepatocellular carcinoma. Quercetin bioflavonoids can decrease HCV production in tissue culture, in part through inhibition of heat shock proteins. If quercetin demonst...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Phytother Res
Autors principals: Lu, Nu T., Crespi, Catherine M., Liu, Natalie M., Vu, James Q., Ahmadieh, Yasaman, Wu, Sheng, Lin, Sherry, McClune, Amy, Durazo, Francisco, Saab, Sammy, Han, Steven, Neiman, David C., Beaven, Simon, French, Samuel W.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5590840/
https://ncbi.nlm.nih.gov/pubmed/26621580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ptr.5518
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars